Never-Smoker Lung Cancer Is Increasing-Reference-Cited by-同舟云学术

Never-Smoker Lung Cancer Is Increasing

Published:2012 Issue:2 Volume:11 Page:89
ISSN:1598-7809
Container-title:Journal of Lung Cancer
language:ko
Short-container-title:J Lung Cancer

Author:

Kang Hyunwook¹²,Park Chan-Woo¹²,Kim Woojin¹²,Song Sang-Yun¹³,Na Kook-Joo¹³,Jeong Jae Uk¹⁴,Yoon Mee Sun¹⁴,Ahn Sung-Ja¹⁴,Choi Yoo-Duk¹⁵,Choi Chan¹⁵,Lee Daun¹⁶,Seon Hyun Ju¹⁶,Kim Yun-Hyeon¹⁶,Kwon Seong Young¹⁷,Bom Hee-Seung¹⁷,Oh In-Jae¹²,Kim Kyu-Sik¹²,Kim Young-Chul¹²

Affiliation:

1. Lung and Esophageal Cancer Clinic, Chonnam National University Hwasun Hospital, Chonnam National University Medical School, Hwasun, Korea.

2. Department of Internal Medicine, Chonnam National University Medical School, Gwangju, Korea.

3. Department of Thoracic and Cardiovascular Surgery, Chonnam National University Medical School, Gwangju, Korea.

4. Department of Radiation Oncology, Chonnam National University Medical School, Gwangju, Korea.

5. Department of Pathology, Chonnam National University Medical School, Gwangju, Korea.

6. Department of Radiology, Chonnam National University Medical School, Gwangju, Korea.

7. Department of Nuclear Medicine, Chonnam National University Medical School, Gwangju, Korea.

Publisher

Korean Association for the Study of Lung Cancer (KAMJE)

Link

https://synapse.koreamed.org/pdf/10.6058/jlc.2012.11.2.89

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Initial low-dose computed tomography screening results and summary of participant characteristics: based on the latest Chinese guideline;Frontiers in Oncology;2023-05-24

2. The High Proportion of Discordant EGFR Mutations among Multiple Lung Tumors;Cancers;2022-06-18

3. Effect of Treatment with the PD-1/PD-L1 Inhibitors on Key Health Outcomes of Cancer Patients;BioDrugs;2020-12-17

4. Role of Low-Dose Computerized Tomography in Lung Cancer Screening among Never-Smokers;Journal of Thoracic Oncology;2019-03

5. Pan-Asian adapted Clinical Practice Guidelines for the management of patients with metastatic non-small-cell lung cancer: a CSCO–ESMO initiative endorsed by JSMO, KSMO, MOS, SSO and TOS;Annals of Oncology;2019-02